Paul Hudson, Sanofi CEO (Raphael Lafargue/Abaca/Sipa USA; Sipa via AP Images)
Sanofi picks up Kadmon and its transplant drug in $1.9B buyout, giving Sam Waksal 2 Big Pharma buyouts under his belt
It’s not just hot spaces that Paul Hudson wants Sanofi to lead in.
The CEO’s latest, $1.9 billion M&A gamble points straight to Kadmon …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.